Synairgen (SNG) Competitors GBX 4.76 +0.26 (+5.77%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines SNG vs. COS, C4XD, DDDD, AREC, SAR, OBI, OKYO, AOR, HEMO, and RLMShould you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Arecor Therapeutics (AREC), Sareum (SAR), Ondine Biomedical (OBI), OKYO Pharma (OKYO), AorTech International (AOR), Hemogenyx Pharmaceuticals (HEMO), and Realm Therapeutics (RLM). These companies are all part of the "biotechnology" industry. Synairgen vs. Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Arecor Therapeutics Sareum Ondine Biomedical OKYO Pharma AorTech International Hemogenyx Pharmaceuticals Realm Therapeutics Collagen Solutions plc (COS.L) (LON:COS) and Synairgen (LON:SNG) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations. Do insiders and institutionals have more ownership in COS or SNG? 30.7% of Synairgen shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, COS or SNG? Collagen Solutions plc (COS.L) has higher revenue and earnings than Synairgen. Synairgen is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollagen Solutions plc (COS.L)£4.01M7.73N/A-£0.80-8.28Synairgen£79K121.47-£42.87M-£0.03-158.83 Is COS or SNG more profitable? Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Synairgen's return on equity.Company Net Margins Return on Equity Return on Assets Collagen Solutions plc (COS.L)N/A N/A N/A Synairgen N/A -48.86%-30.58% Does the MarketBeat Community prefer COS or SNG? Synairgen received 24 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 56.46% of users gave Synairgen an outperform vote. CompanyUnderperformOutperformCollagen Solutions plc (COS.L)Outperform Votes12972.88% Underperform Votes4827.12% SynairgenOutperform Votes15356.46% Underperform Votes11843.54% Does the media favor COS or SNG? In the previous week, Collagen Solutions plc (COS.L)'s average media sentiment score of 0.00 equaled Synairgen'saverage media sentiment score. Company Overall Sentiment Collagen Solutions plc (COS.L) Neutral Synairgen Neutral Do analysts rate COS or SNG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Collagen Solutions plc (COS.L) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASynairgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryCollagen Solutions plc (COS.L) and Synairgen tied by winning 5 of the 10 factors compared between the two stocks. Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNG vs. The Competition Export to ExcelMetricSynairgenBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£9.60M£158.40M£5.40B£1.63BDividend Yield1.53%3.39%5.16%11.03%P/E Ratio-158.83348.23113.091,785.79Price / Sales121.4719,806.471,478.84237,189.75Price / Cash1.9011.3039.8336.67Price / Book0.187.514.642.88Net Income-£42.87M-£18.90M£119.13M£148.87M7 Day Performance5.89%-0.05%0.78%0.11%1 Month Performance27.07%2.54%5.66%-0.11%1 Year Performance-31.83%28.85%36.92%15.75% Synairgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGSynairgenN/AGBX 4.77+5.8%N/A-33.8%£9.60M£79,000.00-158.8334Gap UpCOSCollagen Solutions plc (COS.L)N/AGBX 6.63flatN/A+0.0%£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AGBX 12+27.3%N/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AGBX 16.66flatN/AN/A£30.05M£718,000.00-1.08106ARECArecor TherapeuticsN/AGBX 75+1.4%N/A-59.5%£28.32M£4.90M-267.8610SARSareumN/AGBX 24.23+0.9%N/A-59.2%£26.15M£47,204.00-403.753,211Positive NewsGap DownHigh Trading VolumeOBIOndine BiomedicalN/AGBX 8.80+43.1%N/A-23.4%£24.40M£1.63M-293.33N/ANews CoverageGap UpHigh Trading VolumeOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007Gap DownAORAorTech InternationalN/AGBX 123.50-2.4%N/AN/A£19.99M£539,000.00-33.383HEMOHemogenyx PharmaceuticalsN/AGBX 1.49+19.0%N/A-30.8%£19.97MN/A-149.0014Gap DownRLMRealm TherapeuticsN/AGBX 11.50flatN/AN/A£13.41M£501,919.00-0.66N/A Related Companies and Tools Related Companies Collagen Solutions plc (COS.L) Competitors C4X Discovery Competitors 4D pharma Competitors Arecor Therapeutics Competitors Sareum Competitors Ondine Biomedical Competitors OKYO Pharma Competitors AorTech International Competitors Hemogenyx Pharmaceuticals Competitors Realm Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SNG) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
